why choose us

First received: October 28, 2022

Clinical Trial: Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

Study Status: Completed

Recruit Status: RECRUITING

Condition: High-Grade Glioma

Study Type: INTERVENTIONAL


Official Title: A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults With Inoperable Relapsed or Refractory High-Grade Glioma

Brief Summary: The purpose of this dose finding study is to evaluate the safety and efficacy of 2 different dose levels of CLR 131 in children, adolescents and young adults with relapsed or refractory high-grade glioma (HGG).

Read more